Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
Schachenhofer J, Gruber VE, Fehrer SV, Haider C, Glatter S, Liszewska E, Höftberger R, Aronica E, Rössler K, Jaworski J, Scholl T, Feucht M.
Schachenhofer J, et al. Among authors: jaworski j.
Neuropathol Appl Neurobiol. 2024 Apr;50(2):e12974. doi: 10.1111/nan.12974.
Neuropathol Appl Neurobiol. 2024.
PMID: 38562027